Search results
Here's Why Eli Lilly (LLY) is a Strong Momentum Stock
Zacks via Yahoo Finance Canada· 3 days agoEli Lilly (LLY) Indianapolis, IN based Eli Lilly and Company, one of the world ...
Lilly’s Mounjaro Beats Novo’s Ozempic in Weight Loss, Study Says. The Stocks Battle It Out.
Barrons.com· 2 days agoA new study found that Eli Lilly’s Mounjaro was more successful at helping users lose weight than...
Pfizer advances weight-loss pill in race to lucrative market
Detroit News· 1 hour agoPfizer Inc. is moving forward with a weight-loss pill as the drugmaker seeks to crack the...
Pfizer Moves Forward With Weight-Loss Pill. The Stock Is Rising.
Barrons.com· 3 hours agoPfizer stock was rising Thursday after the pharmaceutical company said it was moving forward with...
Eli Lilly to Buy Morphic for $3.2 Billion. Morphic Stock Nearly Doubles.
Barrons.com· 3 days agoFEATURE Morphic Holding stock was surging Monday after pharmaceutical giant Eli Lilly agreed to...
Weight loss drug Zepbound outperforms Ozempic in new published study
United Press International via Yahoo Canada News· 3 days agoThe active ingredient in Eli Lilly's Mounjaro and Zepbound leads to more weight loss than the active...
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss
Reuters via Yahoo Finance Canada· 2 days agoShares in Novo Nordisk, maker of the wildly popular obesity drug Wegovy, were down 1.9% on Tuesday...
Bloomberg Intelligence: Eli Lilly to Purchase Morphic - Bloomberg
Bloomberg· 3 days agoAlix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company and industry research.
Eli Lilly Remains an Equities Outlier
FX Empire via Yahoo Finance Canada· 6 days agoOn the financial side, the company has a market capitalization of more than $800 billion and has outperformed the broader market over the past 15 years...
Most patients stop using Wegovy, Ozempic for weight loss within two years, analysis finds
Reuters via Yahoo Finance Canada· 1 day agoThe analysis does not include details about why patients quit. Evidence that many people may stop...